Skip to main content

Archived Article — The Daily Perspective is no longer active. This article was published on 27 March 2026 and is preserved as part of the archive. Read the farewell | Browse archive

Health

Sunscreen Scandal Exposes the Limits of Light-Touch Regulation

After major brands failed testing, the TGA proposes an overhaul, but questions remain about whether fixes will restore consumer trust

Sunscreen Scandal Exposes the Limits of Light-Touch Regulation
Image: 7News
Key Points 3 min read
  • Consumer testing found 16 of 20 popular sunscreens failed to meet their SPF claims, with some providing only SPF 4 instead of SPF 50+
  • The TGA relies on manufacturer-submitted data rather than conducting independent pre-market testing
  • Proposed reforms include stricter lab accreditation, alternative testing methods, and simpler labelling categories
  • Some experts say the real issue is not just testing variability but structural gaps in how Australia regulates these critical health products

When a sunscreen labelled SPF 50+ provides the protection of SPF 4, someone has failed. The question is who, and whether Australia's regulatory system can actually be fixed.

A growing sunscreen scandal saw 21 products pulled from Australian shelves after regulators found that several popular brands massively overstated their sun protection, with some products marketed as SPF50+ found to provide as little as SPF4. The trigger was straightforward: Following a CHOICE sunscreen investigation in 2025, over 20 sunscreens were pulled from sale in Australia due to concerns that they did not meet the SPF claims on their label.

This is not merely a quality-control mishap at one factory. CHOICE tested 20 popular SPF50 or SPF50+ sunscreens and found 16 of them didn't meet their SPF claims, with products chosen from a range of brands, retailers, and price points and tested by experts in a specialised, accredited sunscreen lab. The scale of the failure is striking. The fundamental question is this: How did Australia, a country with the world's highest skin cancer rates, allow such products to reach pharmacy shelves in the first place?

The answer implicates the regulator itself. Sunscreens are treated as "listed" medicines, meaning they are not routinely assessed before hitting shelves and are instead policed after the fact. Manufacturers simply certify their products meet standards; the TGA does not independently verify. This is not unique to Australia, but in a country where sun exposure poses existential public health risks, the casual reliance on manufacturer honesty looks reckless in hindsight.

The TGA wants to overhaul SPF testing methodology in Australia and simplify consumer labels from specific numbers to broader categories: low, medium, high, or very high protection. The regulator is now consulting on multiple reforms. Alternatively, it could require that SPF products sold in Australia come from accredited or certified labs, which the TGA says would greatly reduce the "likelihood of inaccurate SPF claims and unsafe products entering the market".

But even this begs harder questions. There is genuine merit to the argument that SPF testing itself is inherently variable. Current methods using human subjects can produce inconsistent results, while some testing laboratories have delivered unreliable data. One sunscreen tested by CHOICE at SPF 4 was later tested by Ultra Violette at SPF 61. Both cannot be right. The current internationally accepted International Organisation for Standardisation (ISO) method of sunscreen SPF testing uses human subjects. Variability of SPF test results associated with the ISO 24444 test is a known problem internationally and domestically.

The counter-argument has weight: If the method is inherently unreliable, then why does a luxury brand's testing show results so radically different from independent verification? The existence of genuine technical complexity does not excuse the gap. The regulator is considering stricter oversight and accreditation of testing labs, clearer and more consistent labelling, and expanded use of more consistent testing methods. Moving to alternative in-vitro methods offers promise, but implementing new standards takes time.

What this scandal reveals is a trust deficit that regulations alone cannot fix. Consumers experienced a "trust deficit" after what has been described as a "hold-on-to-your-hat moment that eroded the premium protection narrative that sunscreen had." Australians have been told for decades that sunscreen is a critical tool in protecting against melanoma. If that message proves hollow because labelled SPF values are fiction, the response may not be compliance with new rules but rejection of the product category itself.

This points to a deeper institutional accountability issue: light-touch regulation works only when the regulated industry acts in good faith. When it does not, the regulator's failure to verify becomes complicity. Australia will eventually have tighter rules. The real test is whether they arrive before more consumers learn their sunscreen cannot be trusted.

Sources (6)
Daniel Kovac
Daniel Kovac

Daniel Kovac is an AI editorial persona created by The Daily Perspective. Providing forensic political analysis with sharp rhetorical questioning and a cross-examination style. As an AI persona, articles are generated using artificial intelligence with editorial quality controls.